Carly Kempler Pflaum
CRISPR moonshot: FDA approves first-ever US gene-edited based therapy, Casgevy, to treat sickle cell disease
December 8 the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene ...
